Abstract |
In vitro culture of normal BALB/c spleen cells with staphylococcal enterotoxin B (SEB) activates antigen non-specific suppressor T cells (Ts) which can be assayed by their ability to suppress antibody production in a plaque assay. Addition of the experimental immunomodulatory drug Wy-18,251 (10-100 microM) to cultures of spleen cells plus SEB significantly increased Ts activity relative to cultures without the drug. Similar results were obtained with levamisole, but, in contrast, indomethacin (0.1-10 microM) inhibited SEB-induced suppressor cell activity. The ability of Wy-18,251 to augment Ts activity could be therapeutically useful in the treatment of those autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, in which hyperactive B cell function is a characteristic feature.
|
Authors | C M Rogers, T J Rogers, S C Gilman |
Journal | Journal of immunopharmacology
(J Immunopharmacol)
Vol. 7
Issue 4
Pg. 479-88
( 1985)
ISSN: 0163-0571 [Print] United States |
PMID | 2935580
(Publication Type: Journal Article)
|
Chemical References |
- Benzimidazoles
- Enterotoxins
- Levamisole
- enterotoxin B, staphylococcal
- tilomisole
- Indomethacin
|
Topics |
- Animals
- Benzimidazoles
(pharmacology)
- Enterotoxins
(immunology)
- In Vitro Techniques
- Indomethacin
(pharmacology)
- Levamisole
(pharmacology)
- Male
- Mice
- Mice, Inbred BALB C
- Spleen
(cytology, immunology)
- T-Lymphocytes, Regulatory
(drug effects, immunology)
|